Literature DB >> 15586796

Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis.

Jean-Baptiste Watelet1, Cindy Claeys, Claudina Perez-Novo, Philippe Gevaert, Paul Van Cauwenberge, Claus Bachert.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) and nasal polyposis (NP) are histopathologically characterized by different gross morphological aspects. Transforming growth factor (TGF) beta1 plays an important role in tissue remodeling, which is poorly understood in chronic diseases of the sinuses.
METHODS: The expression of TGF-beta1 was analyzed by enzyme-linked immunosorbent assay, quantitative reverse-transcription polymerase chain reaction, and immunohistochemistry in nasal tissue from controls (n = 6), CRS (n = 19), or NP (n = 19).
RESULTS: CRS presented significantly higher concentrations of TGF-beta1 at protein (p = 0.0008) and mRNA levels (p = 0.025) when compared with NP samples. In CRS, TGF-beta1+ staining of the extracellular matrix was found abundantly and related to fibrosis. In contrast, no TGF-beta1 staining was found in the pseudocyst areas in NP.
CONCLUSION: CRS was histologically characterized by fibrosis, which was reflected by a significantly higher expression of TGF-beta1 at RNA and protein levels when compared with NP. We show that TGF-beta1 expression is related to fibrosis, differentiating CRS without polyps from NP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15586796

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  18 in total

1.  Relationship of TLR2, TLR4 and tissue remodeling in chronic rhinosinusitis.

Authors:  Xin Wang; Chunyuan Zhao; Wenjun Ji; Yuan Xu; Huamin Guo
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Tissue remodeling gene expression in a murine model of chronic rhinosinusitis.

Authors:  Nathan B Sautter; Katherine L Delaney; Frances A Hausman; Dennis R Trune
Journal:  Laryngoscope       Date:  2012-01-31       Impact factor: 3.325

Review 3.  Pharmacological management of nasal polyposis.

Authors:  Claus Bachert; Jean-Baptiste Watelet; Philippe Gevaert; Paul Van Cauwenberge
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Pathogenesis of nasal polyposis.

Authors:  K E Hulse; W W Stevens; B K Tan; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

5.  Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis.

Authors:  Hyun Sil Lee; Allen Myers; Jean Kim
Journal:  Am J Respir Crit Care Med       Date:  2009-09-17       Impact factor: 21.405

6.  Smoking-associated squamous metaplasia in olfactory mucosa of patients with chronic rhinosinusitis.

Authors:  Karen K Yee; Edmund A Pribitkin; Beverly J Cowart; Aldona A Vainius; Christopher T Klock; David Rosen; Chang-Gyu Hahn; Nancy E Rawson
Journal:  Toxicol Pathol       Date:  2009-06-01       Impact factor: 1.902

7.  Pathophysiological classification of chronic rhinosinusitis.

Authors:  James N Baraniuk; Hilda Maibach
Journal:  Respir Res       Date:  2005-12-19

8.  Inhibitory Effect of Delphinidin on Extracellular Matrix Production via the MAPK/NF-κB Pathway in Nasal Polyp-Derived Fibroblasts.

Authors:  Jung Sun Cho; Ju Hyung Kang; Jae Min Shin; Il Ho Park; Heung Man Lee
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-05       Impact factor: 5.764

9.  Activation of Activin receptor-like kinases curbs mucosal inflammation and proliferation in chronic rhinosinusitis with nasal polyps.

Authors:  Lotta Tengroth; Julia Arebro; Olivia Larsson; Claus Bachert; Susanna Kumlien Georén; Lars-Olaf Cardell
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

10.  Epithelium and stroma from nasal polyp mucosa exhibits inverse expression of TGF-β1 as compared with healthy nasal mucosa.

Authors:  Leonardo Balsalobre; Rogério Pezato; Claudina Perez-Novo; Maria Teresa S Alves; Rodrigo P Santos; Claus Bachert; Luc L M Weckx
Journal:  J Otolaryngol Head Neck Surg       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.